...
首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >Dosimetric evaluation of a commercial 3-D treatment planning system using Report 55 by AAPM Task Group 23.
【24h】

Dosimetric evaluation of a commercial 3-D treatment planning system using Report 55 by AAPM Task Group 23.

机译:AAPM任务组23使用报告55对商业3D治疗计划系统进行剂量学评估。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND PURPOSE: A relevant part of radiotherapy treatment planning system QA concerns dose calculation verification. Report 55 by AAPM TG-23 is an instrument for performing dosimetric evaluation of treatment planning systems in case of external photon beams. It was employed by different groups in three radiotherapy departments for controlling performances of RTPS CadPlan Varian-Dosetek, versions 2.7.9, 3.0.6 and 3.1.1. MATERIALS AND METHODS: Once the basic data of the AAPM 4 MV and 18 MV X-ray units had been converted into the CadPlan format and the AAPM units configured, the whole set of TG23 tests were carried out on three different systems. According to Report 55, comparisons between values measured by TG-23 and calculated by RTPS were made in terms of dose at selected points and radiological field width at different depths. RESULTS: As far as dose is concerned, 266 data were compared for 4 MV and 297 for 18 MV. Ninety-five-point-nine percent of dose deviations for 4 MV and 92.6% for 18 MV are less than 2%. Most of the relevant discrepancies for both energies occur in a test case where dose has to be calculated under a long narrow block centred on the beam axis. Deviations as much as 6.1% for 4 MV and -7.5% for 18 MV were observed in points at 1 cm depth under the block. Poor results were also observed in the rectangular field 25 x 5, in points outside the field edges under collimators. As regards radiological field width, 58 out of 64 comparisons for 4 MV occurred in the range +/- 2 mm. For 18 MV the biggest deviation was -2.2 mm. CONCLUSIONS: The TG-23 tests demonstrated that the accuracy of the RTPS in dose calculation is good in most of the typical radiotherapy applications. Our results are better than those recently published for other RTPS. The TG-23 package turned out to be an effective instrument for QA and calculation verification, as well as being a powerful method for training purpose in configuring and using a RTPS.
机译:背景与目的:放射治疗计划系统QA的相关部分涉及剂量计算验证。 AAPM TG-23的报告55是一种用于在外部光子束的情况下对治疗计划系统进行剂量评估的仪器。它被三个放疗科的不同小组雇用,以控制RTPS CadPlan Varian-Dosetek(版本2.7.9、3.0.6和3.1.1)的性能。材料与方法:将AAPM 4 MV和18 MV X射线单元的基本数据转换为CadPlan格式并配置AAPM单元后,将在三个不同的系统上进行整套TG23测试。根据报告55,根据选定点的剂量和不同深度的放射线宽度,对TG-23测量值和RTPS计算值之间进行了比较。结果:就剂量而言,比较了4 MV的266数据和18 MV的297数据。 4 MV的剂量偏差为百分之九十五,而18 MV的偏差为92.6%小于2%。两种能量的大多数相关差异发生在测试案例中,在这种情况下,必须在以光束轴为中心的长而狭窄的区域下计算剂量。在块下1 cm深度的点中观察到4 MV的偏差高达6.1%,18 MV的偏差高达-7.5%。在矩形场25 x 5中,在准直仪下场边缘外侧的点中也观察到了差的结果。关于放射线宽度,在64例4 MV的比较中,有58例发生在+/- 2 mm范围内。对于18 MV,最大偏差为-2.2毫米。结论:TG-23测试表明,RTPS在剂量计算中的准确性在大多数典型放射治疗应用中都很好。我们的结果优于其他RTPS的最新结果。 TG-23软件包被证明是进行质量检查和计算验证的有效工具,并且是用于配置和使用RTPS的强大培训方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号